ranolazine umedica 750mg tableta s prodlouženým uvolňováním
umedica netherlands b.v., amsterdam array - 10704 ranolazin - tableta s prodlouženým uvolňováním - 750mg - ranolazin
corvapro neo 10mg potahovaná tableta
novatin limited, mosta array - 16812 vÁpenatÁ sŮl rosuvastatinu - potahovaná tableta - 10mg - rosuvastatin
corvapro neo 20mg potahovaná tableta
novatin limited, mosta array - 16812 vÁpenatÁ sŮl rosuvastatinu - potahovaná tableta - 20mg - rosuvastatin
corvapro neo 40mg potahovaná tableta
novatin limited, mosta array - 16812 vÁpenatÁ sŮl rosuvastatinu - potahovaná tableta - 40mg - rosuvastatin
corvapro neo 5mg potahovaná tableta
novatin limited, mosta array - 16812 vÁpenatÁ sŮl rosuvastatinu - potahovaná tableta - 5mg - rosuvastatin
sitagliptin/metformin reddy 50mg/850mg potahovaná tableta
reddy holding gmbh, augsburg array - 41 monohydrÁt sitagliptin-hydrochloridu; 2418 metformin-hydrochlorid - potahovaná tableta - 50mg/850mg - metformin a sitagliptin
esoprex orotab 10mg tableta dispergovatelná v ústech
zentiva, k.s., praha ČeskÁ republika - 16590 escitalopram-oxalÁt - tableta dispergovatelná v ústech - 10mg - escitalopram
hydroxychloroquine sulfate accord 200mg potahovaná tableta
accord healthcare polska sp. z o.o., varšava array - 741 hydroxychlorochin-sulfÁt - potahovaná tableta - 200mg - hydroxychlorochin
sitagliptin accord
accord healthcare s.l.u. - sitagliptin hydrochloride - diabetes mellitus, typ 2 - léky užívané při diabetu - for adult patients with type 2 diabetes mellitus, sitagliptin accord is indicated to improve glycaemic control:as monotherapy:- in patients inadequately controlled by diet and exercise alone and for whom metformin is inappropriate due to contraindications or intolerance. as dual oral therapy in combination with:- metformin when diet and exercise plus metformin alone do not provide adequate glycaemic control. - a sulphonylurea when diet and exercise plus maximal tolerated dose of a sulphonylurea alone do not provide adequate glycaemic control and when metformin is inappropriate due to contraindications or intolerance. - a peroxisome proliferator-activated receptor gamma (ppary) agonist (i. a thiazolidinedione) when use of a ppary agonist is appropriate and when diet and exercise plus the ppary agonist alone do not provide adequate glycaemic control. as triple oral therapy in combination with:- a sulphonylurea and metformin when diet and exercise plus dual therapy with these medicinal products do not provide adequate glycaemic control. - a ppary agonist and metformin when use of a ppary agonist is appropriate and when diet and exercise plus dual therapy with these medicinal products do not provide adequate glycaemic control. sitagliptin accord is also indicated as add-on to insulin (with or without metformin) when diet and exercise plus stable dose of insulin do not provide adequate glycaemic control.
ezetimibe glenmark 10mg tableta
glenmark pharmaceuticals s.r.o., praha array - 16227 ezetimib - tableta - 10mg - ezetimib